Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study in healthy volunteers to compare BR3006 alone with co-administration of BR3006A, BR3006B, and BR3006C; recruitment is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• BR3006
• BR3006A
• BR3006B
• BR3006C

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Diabetes Mellitus | Phase 1 | Status: RECRUITING